AOD 9604, a synthetic fragment of growth hormone, has risen to prominence as a promising therapeutic agent for facilitating fat loss. This compound exerts its effects by targeting lipid stores, promoting the catabolism of triglycerides and suppressing lipogenesis, the process of fat synthesis. Preclinical studies have demonstrated AOD 9604's abilit
Your Partner for FDA-Approved Peptides in the USA
When seeking a reliable partner for your peptide development journey in the United States, look no further than [Company Name]. As a leading CDMO specializing in peptides, we provide comprehensive solutions from research and development to GMP synthesis. Our commitment to quality is unwavering, ensuring all our peptides meet the stringent standards